Dr. Sudhir Agrawal

Scientific Advisor

Dr. Sudhir Agrawal is a globally recognized leader in oligonucleotide research and drug development, with a distinguished career spanning scientific innovation, entrepreneurship, and leadership. He is the Founder & President of ARNAY Sciences LLC and the Founder of Idera Pharmaceuticals, where he held key leadership roles, including Chairman, CEO, President of Research, and Chief Scientific Officer.

In academia, Dr. Agrawal serves as a Visiting Professor in the Department of Medicine at The University of Massachusetts Medical School and is a member of the Business Advisory Board for The Harvard Medical School’s Initiative for RNA Medicine. His contributions to the field are extensive, having edited four books on oligonucleotides and antisense technology, published over 300 research papers, and co-invented more than 400 patents worldwide.

With his deep expertise and visionary leadership, Dr. Agrawal continues to drive advancements in RNA therapeutics and precision medicine.